Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rational treatment for dyslipidemias

E M Verzino1, B Kaplan

  • 1Charleston Area Medical Center, W.Va.

The West Virginia Medical Journal
|February 1, 1994
PubMed
Summary

Managing high blood cholesterol, a key cardiovascular disease risk factor, involves lifestyle changes and various medications. This review details common antihyperlipidemic agents, considering their effectiveness, side effects, and costs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mueller matrix of dense polystyrene latex sphere suspensions: measurements and Monte Carlo simulation.

Applied optics·2008
Same author

Use of low dose tacrolimus, mycophenolate mofetil and maintenance IL-2 receptor blockade in an islet transplant recipient.

Clinical transplantation·2008
Same author

Phase-modulated mueller ellipsometry characterization of scattering by latex sphere suspensions.

Applied optics·2008
Same author

Comparison of visual function and ocular hemodynamics between pre- and post-menopausal women.

European journal of ophthalmology·2008
Same author

Prophylaxis versus preemptive protocols for CMV: do they impact graft survival?

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2008
Same author

Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: should we treat?

Journal of the European Academy of Dermatology and Venereology : JEADV·2008

Area of Science:

  • Cardiology
  • Pharmacology
  • Metabolic Disorders

Background:

  • High blood cholesterol is a primary risk factor for cardiovascular disease.
  • Dietary modifications (low cholesterol, low saturated fats) are the initial treatment.
  • Effective management requires considering patient-specific factors like concurrent conditions and drug profiles.

Purpose of the Study:

  • To review commonly prescribed antihyperlipidemic agents.
  • To compare different classes of cholesterol-lowering drugs.
  • To inform therapeutic choices based on individual patient needs.

Main Methods:

  • Literature review of antihyperlipidemic agents.
  • Analysis of drug classes including bile-acid sequestrants, nicotinic acid, fibric-acid derivatives, and HMG-CoA reductase inhibitors.
  • Evaluation of pharmacological properties, efficacy, and safety profiles.

Main Results:

  • Antihyperlipidemic agents differ significantly in mechanism, effectiveness, pharmacokinetics, and side effects.
  • HMG-CoA reductase inhibitors, bile-acid sequestrants, nicotinic acid, and fibric-acid derivatives represent major drug classes.
  • Therapeutic selection depends on lipid abnormality type, patient comorbidities, and drug-specific characteristics.

Conclusions:

  • The choice of antihyperlipidemic therapy necessitates a comprehensive assessment of drug attributes and patient status.
  • Understanding the nuances between different dyslipidemic agents is crucial for optimizing cardiovascular risk reduction.
  • Personalized treatment strategies are essential for managing high cholesterol effectively.

Related Experiment Videos